Cormedix Inc (CRMD) 8.86 $CRMD Immunomedics (IMMU)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cormedix Inc (CRMD) 8.86 $CRMD

Immunomedics (IMMU) Provides Update on Lead ADC Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 1:45PM CDT
Immunomedics, Inc. (IMMU) provided an update on its lead ADC candidate, sacituzumab govitecan.
CRMD: 8.86 (-0.28), BIIB: 423.57 (+1.46), IMMU: 4.14 (-0.04)

Illumina (ILMN) Tops Q1 Earnings, Revenues; EPS View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 9:15AM CDT
Illumina (ILMN) has started off 2015 on a positive note with remarkable first-quarter results, which mark the 14th consecutive quarter of sequential revenue growth.
CRMD: 8.86 (-0.28), BIIB: 423.57 (+1.46), CYTX: 0.96 (-0.09), ILMN: 190.04 (-9.27)

Actavis' Botox Upper Limb Spasticity Label Expanded by FDA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 3:08PM CDT
Actavis' (ACT) Botox has been granted further FDA approval; adds upper limb spasticity to its label.
CRMD: 8.86 (-0.28), BIIB: 423.57 (+1.46), ACT: 295.22 (+0.69), AVEO: 2.04 (+0.12)

4 Stocks Under $10 Making Big Moves
at The Street - Thu Apr 16, 1:11PM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
CRMD: 8.86 (-0.28), MCEP: 6.13 (+0.11), NTLS: 5.46 (+0.17), OCLS: 0.84 (-0.01)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Thu Apr 09, 8:11AM CDT

MEMP: 16.95 (-0.16), CRMD: 8.86 (-0.28), INO: 10.39 (-0.09), AMCN: 4.43 (+0.44), QURE: 26.15 (-1.44), ALTR: 42.78 (-0.46), BIOS: 5.23 (+0.04), NVGN: 7.40 (-0.30), ZNGA: 2.51 (+0.02), DGLY: 13.13 (+0.08), INFN: 19.79 (-0.43), EXEL: 3.12 (+0.05)

CorMedix Institutes Program to Reduce Neutrolin® Cost of Goods; Reports on Strategic Review Process Managed by Evercore
PR Newswire - Thu Apr 09, 7:00AM CDT
CorMedix Inc. (NYSE MKT: CRMD), a global biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases, today announced a significant new program aimed at enhancing long term market competitiveness by substantially reducing the cost of goods of Neutrolin® Catheter Lock Solution through a more efficient, custom synthesis of the active ingredient taurolidine.
CRMD: 8.86 (-0.28)

CorMedix: High Probability Of Phase 3 Success?
Pharma Investor - at Seeking Alpha - Wed Apr 08, 12:49PM CDT

CRMD: 8.86 (-0.28)

Healthcare stock screen of the month: Price extended, poor fundamentals
Seeking Alpha - at Seeking Alpha - Wed Apr 08, 12:05PM CDT

CRMD: 8.86 (-0.28), ADXS: 22.18 (+0.10), CYTX: 0.96 (-0.09), CNDO: 4.09 (-0.09), AMRN: 2.34 (-0.05), AVEO: 2.04 (+0.12), NVGN: 7.40 (-0.30), AXN: 1.77 (+0.01), NYMX: 1.32 (-0.08), DRRX: 2.19 (+0.10), RIGL: 4.24 (+0.07), CAPN: 6.99 (-0.29)

The Top-Performing Biotech Stock During a Sizzling First Quarter
at The Street - Wed Apr 01, 8:30AM CDT
That was one crazy first quarter for the biotech sector. Here's where biotech stocks stand on April Fool's Day.
CRMD: 8.86 (-0.28), BIIB: 423.57 (+1.46), ESPR: 100.53 (-2.60), FMI: 48.71 (-0.96), ANTH: 4.79 (+0.10), XBI: 232.63 (-0.32), IBB: 363.84 (-0.66), TRIL: 20.67 (-2.53)

CorMedix Receives Audit Opinion with Going Concern Explanation
PR Newswire - Tue Mar 31, 5:00PM CDT
CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases, today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2014, which was filed on March 12, 2015, the audited financial statements for the year ended December 31, 2014 contained in the Form 10-K contained an audit opinion from its independent registered public accounting firm which includes a going concern qualification.
CRMD: 8.86 (-0.28)

3 Small Cap Pharma Stocks Set to Surge Following Q1 Earnings - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Tue Mar 31, 1:33PM CDT
Healthcare has been a great place to invest in over the last few years, but pharmaceuticals have done even better...3 pharma stocks
CRMD: 8.86 (-0.28), IHE: 178.66 (-0.18), IYH: 157.86 (+0.08), HZNP: 30.96 (+0.10), STML: 16.51 (+0.13)

Will CorMedix (CRMD) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 31, 7:03AM CDT
Will CorMedix (CRMD) Continue to Surge Higher?
CRMD: 8.86 (-0.28)

CorMedix (CRMD): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 30, 7:34AM CDT
CorMedix (CRMD) in the Medical – Biomed/Gene space is seeing solid earnings estimate revisions and has a great Zacks Industry Rank.
CRMD: 8.86 (-0.28)

Technical Scrutiny on Biotech Stocks -- Exact Sciences, Galena Biopharma, Alkermes, Seattle Genetics, and CorMedix
PR Newswire - Thu Mar 26, 8:00AM CDT
Editor Note: For more information about this release, please scroll to bottom.
CRMD: 8.86 (-0.28), SGEN: 36.92 (-0.32), GALE: 1.39 (unch), EXAS: 22.28 (+0.24), ALKS: 62.60 (-0.24)

CorMedix Announces Effectiveness of Registration Statements for Shares Underlying Publicly Traded Warrants
PR Newswire - Fri Mar 20, 7:00AM CDT
CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases, today announced that the registration statements for the shares of its common stock underlying its publicly traded warrants with CUSIP number (No.21900C118) have both been declared effective by the Securities and Exchange Commission. Holders of publicly traded warrants who wish to exercise their warrants will receive freely tradable shares of common stock upon presentation of a properly completed exercise notice and full payment for exercise. As previously reported, the expiration date for these publicly traded warrants is April 30, 2015.
CRMD: 8.86 (-0.28)

CorMedix (CRMD) Looks Good: Stock Moves 8.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 18, 8:25AM CDT
CorMedix (CRMD) was a big mover last session, with shares rising roughly 9% on the day.
CRMD: 8.86 (-0.28), AFFX: 12.57 (-0.13)

Borrow Costs Elevated On CorMedix
Interactive Brokers - at Seeking Alpha - Tue Mar 17, 2:09AM CDT
CorMedix, Inc. (NYSEMKT: CRMD ) continues to be a difficult borrow as demand has far exceeded the lendable supply. Over the past two weeks the amount of shares traded in the cash market has been well above historical averages while the amount of...
CRMD: 8.86 (-0.28), EYES: 13.26 (-0.06), SHAK: 62.00 (+2.00), MELA: 1.52 (-0.14), GME: 40.24 (+0.16), AMRN: 2.34 (-0.05), AXN: 1.77 (+0.01), FXCM: 2.13 (+0.02), WBAI: 16.75 (-0.46), RESN: 3.77 (-0.06), WPRT: 4.39 (+0.01), RIG: 16.85 (-0.18), CYTX: 0.96 (-0.09), CEN: 16.93 (+0.07), CAPN: 6.99 (-0.29)

CorMedix's (CRMD) CEO Randy Milby on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Mar 13, 4:36PM CDT

CRMD: 8.86 (-0.28)

Seeking Alpha's Biotech Weekly: Deeper Looks At Orexigen, Pharmacyclics, And Acadia
SA Editor Mike Taylor - Seeking Alpha - Fri Mar 13, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
ACT: 295.22 (+0.69), PCYC: 256.98 (-0.77), ITEK: 4.80 (-0.02), REDX: (), PTX: 7.44 (-0.05), CLDX: 28.95 (+1.08), ILMN: 190.04 (-9.27), IDGX: (), ACAD: 38.55 (-0.20), TRGT: 2.30 (-0.02), CLLS: 31.30 (-0.91), EXAC: 24.15 (+0.15), ABBV: 64.52 (+0.91), CRMD: 8.86 (-0.28), AGMX: (), ZGNX: 1.63 (-0.02), VVUS: 2.50 (+0.04), SPPI: 5.98 (+0.04), GSK: 46.57 (-0.67), OREX: 7.39 (+0.22), SQNM: 4.47 (+0.08), IRWD: 15.07 (-0.19), GILD: 104.18 (-1.02), MRK: 57.69 (+0.03), OHRP: 2.72 (+0.08), TEVA: 63.01 (-1.15)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Small Business Insurance Is a Costly Blind Spot Today

Updated Category News Views 32

A busted pipe, a fender-bender, or one bad fall can turn a promising little company into a very expensive regret. That is the plain-English value in insurance expert Michael Oehrke's overview for HelloNation: small-business insurance is not glamorous, it is not growth marketing, and it is often ignored until the owner is staring at a bill that can chew through years of...

Continue Reading
LevelTen Takes Its Clean-Power Market Model to India

Updated Category News Views 89

India's power market is not a tidy spreadsheet, thankfully. It is a vast, fast-growing grid where data centres, factories and climate exposure are all colliding with a generation mix still dominated by coal. That is why LevelTen Energy's move into Asia-Pacific deserves more than the usual clean-tech applause line. Beginning with a 500 MW clean-energy request for proposals...

Continue Reading
Vizsla's Panuco Delay Puts Security Ahead of Speed

Updated Category News Views 73

A mine schedule can absorb a calendar slip; the people around a mine cannot be treated like a line item. Vizsla Silver's update on Panuco is therefore not the usual development-company chest thumping. It is a sober admission that security, permitting and site readiness have pushed first silver to the second half of 2028, one year later than the prior H2 2027 target....

Continue Reading
Abbe Lane Estate Puts Jewelry Demand on Full Display

Updated Category News Views 40

Glamour Is Walking Back Into the Auction Room Abbe Lane’s jewelry is not being offered as a vague nostalgia exercise; it is arriving with dates, a setting, and a clear split between two December sales. John Moran Auctioneers will lead with The Estate of Abbe Lane on Wednesday, December 9, 2026, at 10:00 a.m. PST, then follow with its Jewelry & Watches auction on...

Continue Reading
Elijah Craig Uses AI Toasts to Sell a Warmer Pour

Updated Category News Views 129

A Speech Prompt With a Bourbon Label Few things expose holiday nerves faster than a raised glass and a room waiting for somebody to say something memorable. Elijah Craig has decided that awkward little moment is marketing territory, rolling out its Digital Perfect Pour, Perfect Toast Generator for mobile and desktop users ahead of the holiday season. The tool asks for a...

Continue Reading
Stanford Forum Puts Industrial AI in the Real World

Updated Category News Views 18

Factory Data Is Not a Free Lunch A factory dataset is worth precisely nothing if its owner cannot control it. That was the hard-nosed thread running through the ASI City Forum at Stanford on November 17: industrial AI is not just about smarter models or splashy chip announcements. It is about whether manufacturers will trust a system with proprietary operating data,...

Continue Reading
Disney Springs Hotel Rates Test Holiday Demand Depth

Updated Category News Views 192

A $145 room rate is the sort of holiday bait that gets my attention before the fake snow does. Disney Springs Resort Area Hotels are extending a seasonal offer for stays through Dec. 18, 2026, with bookings open only through Nov. 20. That is a very narrow selling window, and it tells you plenty: these seven independent hotels want to fill rooms during a lucrative but...

Continue Reading
LiberNovo's Black Friday Chair Sale Tests Premium Demand

Updated Category News Views 62

Ergonomic chairs are not impulse purchases, and LiberNovo knows it. Its Black Friday push in the United States and Canada runs through November 30, throwing discounts, gifts, prize-wheel entries and loyalty points at buyers considering a fairly expensive piece of office equipment. That is a lot of promotional machinery for a chair sale, but the underlying pitch is...

Continue Reading
Rescue Dog Wines Puts Holiday Bottles to Work for Dogs

Updated Category News Views 74

A Bottle With a Job Beyond the Table Holiday wine promotions usually arrive wrapped in the same tired ribbon: buy more, save a little, pour it at a party, forget it by January. Rescue Dog Wines is taking a more grounded route. The family-owned Lodi-area winery says it gives 50% of profits to animal rescue organizations, and that commitment is not being dressed up as a...

Continue Reading
Pacific Surfliner Faces Thanksgiving Capacity Test

Updated Category News Views 122

Thanksgiving traffic on Southern California freeways is its own yearly punishment, and the Pacific Surfliner is making a sensible pitch: leave the car parked and let the coast roll past the window. For travelers, that can be a real relief. For anyone watching public transportation, this is also a useful little stress test of whether a busy state-supported rail corridor...

Continue Reading

Top 5 Most Recently Viewed Articles

Legit Security Named as a Top Performer in Application Security

Updated Category News Views 210

Legit Security Recognized as a Leader in Application Security Legit Security, a leader in AI-native Application Security Posture Management (ASPM), has recently been acknowledged as a prominent player in the IDC MarketScape for ASPM. This achievement reflects the company's commitment to securing AI-powered application development processes. The IDC MarketScape report...

Continue Reading
Active Dental Transforms Patient Experience with New Website

Updated Category News Views 140

Active Dental Enhances Patient Accessibility with Unified Website Active Dental, a reputable family and general dentistry practice in the Dallas-Fort Worth metroplex, has launched a newly redesigned website that seamlessly integrates all five of its practice locations into a single, user-friendly digital platform. This significant upgrade aims to make appointment...

Continue Reading
Stork Club's Innovative Approach to Postpartum Depression Support

Updated Category News Views 229

Stork Club Innovates Reproductive Health Care Stork Club has recently launched an unprecedented initiative aimed at addressing postpartum depression (PPD) among working mothers. This pioneering program offers a seamless blend of digital diagnostics and therapy, leading to significant improvements in mental health outcomes. With up to 20% immediate relief from PPD symptoms...

Continue Reading
Investors Eye Class Action Against Fortrea Holdings, Inc.

Updated Category News Views 114

Understanding the Fortrea Holdings, Inc. Class Action Fortrea Holdings, Inc. (NASDAQ: FTRE) has gained attention due to rising investor concerns regarding its recent financial disclosures. Investors who have experienced losses over $100,000 are now presented with an opportunity to potentially lead a securities fraud lawsuit against the company. This lawsuit highlights...

Continue Reading
Alpha Tau Medical Plans Engagements at Key Healthcare Events

Updated Category News Views 91

Upcoming Participation in Major Healthcare Conferences Alpha Tau Medical Ltd., a leading developer of innovative cancer therapies, is gearing up for an exciting presence at significant healthcare conferences. The involvement of the Chief Financial Officer, Raphi Levy, at these events marks a pivotal opportunity for the company to showcase its groundbreaking...

Continue Reading